Gene · 7296
Papers4,270
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 4,270
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| RNA-Seq of Gingival Fibroblasts Grown on Collagen Membranes and Hyaluronic Acid. | J Funct Biomater | 2026 | 41745519 | PubTator, text mining | PubMed |
| Paraptosis Turning Cellular Stress into Therapeutic Weapon for Urological Diseases. | Research (Wash D C) | 2026 | 41743851 | PubTator, text mining | PubMed |
| Identification of programmed cell death and mitochondria correlated biomarkers for Kawasaki disease by integrated bioinformatics and machine-learning algorithms with RT-qPCR verification. | Front Genet | 2026 | 41743406 | PubTator, text mining | PubMed |
| Flow-dependent NRF2 dysfunction via KEAP1/WDR23 dual repression contributes to endothelial oxidative damage in venous disease. | Biomed Pharmacother | 2026 | 41740371 | PubTator, text mining | PubMed |
| Ferroptosis and immunity: rewiring the tumor microenvironment for therapy. | RSC Adv | 2026 | 41726230 | PubTator, text mining | PubMed |
| The role of antioxidants in multiple myeloma: diagnostic, prognostic, and therapeutic applications: a narrative review. | Ther Adv Hematol | 2026 | 41725790 | PubTator, text mining | PubMed |
| Proteomic Insights into Heroin Use: Links to Neurodegeneration. | Mol Neurobiol | 2026 | 41721130 | PubTator, text mining | PubMed |
| Repeated Sprint Training in Heat Improves Repeated Sprint Ability Under Temperate Conditions Similarly in Active Males and Females. | Eur J Sport Sci | 2026 | 41720497 | PubTator, text mining | PubMed |
| Genetics of selenoproteins and selenoprotein metabolism - An overview of current concepts and emerging aspects. | Redox Biol | 2026 | 41719757 | PubTator, text mining | PubMed |
| Editorial: Application of novel biomarkers and natural compounds in precision oncology. | Front Cell Dev Biol | 2026 | 41716287 | PubTator, text mining | PubMed |
| Bixin Beyond Colour: Expanding Therapeutic Horizons Through the Integration of Pharmacological Potential with Modern Drug Design and Delivery Strategies. | Drug Des Devel Ther | 2026 | 41710583 | PubTator, text mining | PubMed |
| Beyond Thiol-Enzyme Inhibition: Sterically Bulky NHC-Au(I) Complexes are Catalytically Active Anticancer Agents with Reprogrammed Immunomodulatory Function. | J Am Chem Soc | 2026 | 41700834 | PubTator, text mining | PubMed |
| AI-based quantification of tumor-infiltrating lymphocytes with integrative transcriptomics in ovarian clear cell carcinoma: JGOG3025-TR1/A1 study. | Cancer Immunol Immunother | 2026 | 41697393 | PubTator, text mining | PubMed |
| Identification of a novel chalcone derivative as ferroptosis inducer through targeting TrxR in prostate cancer. | Biochem Pharmacol | 2026 | 41611135 | PubTator, text mining | PubMed |
| Molecular determinants of allosteric modulation of protein disulfide isomerase by small-molecule b'-ligands. | Redox Biol | 2026 | 41610518 | PubTator, text mining | PubMed |
| Araliadiol Protects Human Keratinocytes From Oxidative Stress, DNA Damage, and Apoptosis via Activation of Antioxidant Signaling. | Front Biosci (Landmark Ed) | 2026 | 41609079 | PubTator, text mining | PubMed |
| Identification of benzo(a)pyrene-mediated ferroptosis to impact prognosis prediction and immune microenvironment with network toxicology in lung adenocarcinoma. | Ecotoxicol Environ Saf | 2026 | 41601062 | PubTator, text mining | PubMed |
| QSOX1: A Mysterious Golgi-Localized Disulfide Bond Catalyst and an Emerging Cancer Regulator. | Cancers (Basel) | 2026 | 41595257 | PubTator, text mining | PubMed |
| Nanozyme-based therapies for inflammatory immune disorders: opportunities and challenges. | Inflamm Res | 2026 | 41591456 | PubTator, text mining | PubMed |
| Bioinformatics analysis and population sample validation of ferroptosis-related genes in coronary heart disease: A case-control study. | Medicine (Baltimore) | 2026 | 41578467 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7296/papers?page=7